ACADIA Pharmaceuticals Inc (ACAD) Insider Trading
- $578,210,290.42
- $97,335,442.43
- March 26, 2025
- Stephen Davis
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 15, 2015 | Director | 27,973 | $33.02 | Sell | $923,668.46 | |
| Jan. 14, 2015 | CEO | 30,000 | $33.98 | Sell | $1,019,400.00 | |
| Dec. 15, 2014 | Director | 12,250 | $31.74 | Sell | $388,815.00 | |
| Dec. 15, 2014 | CEO | 30,000 | $31.00 | Sell | $930,000.00 | |
| Nov. 26, 2014 | CMO | 25,000 | $30.09 | Sell | $752,250.00 | |
| Nov. 26, 2014 | Director | 15,000 | $30.05 | Sell | $450,750.00 | |
| Nov. 24, 2014 | CEO | 30,000 | $29.28 | Sell | $878,400.00 | |
| Nov. 21, 2014 | Director | 5,810 | $29.00 | Sell | $168,490.00 | |
| Oct. 8, 2014 | CEO | 30,000 | $24.15 | Sell | $724,500.00 | |
| Sept. 15, 2014 | Director | 10,000 | $28.07 | Sell | $280,700.00 | |
| Sept. 12, 2014 | Director | 9,190 | $29.15 | Sell | $267,888.50 | |
| Sept. 10, 2014 | CEO | 30,000 | $27.36 | Sell | $820,800.00 | |
| Aug. 15, 2014 | CEO | 15,000 | $22.89 | Sell | $343,350.00 | |
| July 14, 2014 | CEO | 20,000 | $22.22 | Sell | $444,400.00 | |
| June 16, 2014 | CEO | 20,000 | $23.10 | Sell | $462,000.00 | |
| June 9, 2014 | Director | 15,000 | $23.03 | Sell | $345,450.00 | |
| May 1, 2014 | Director | 32,857 | $20.03 | Sell | $658,125.71 | |
| April 15, 2014 | CEO | 25,000 | $17.75 | Sell | $443,750.00 | |
| April 4, 2014 | Director | 30,000 | $21.98 | Sell | $659,400.00 | |
| April 4, 2014 | CFO | 15,000 | $22.48 | Sell | $337,200.00 | |
| March 5, 2014 | Director | 526,316 | $28.50 | Buy | $15,000,006.00 | |
| Feb. 26, 2014 | VP | 42,000 | $30.28 | Sell | $1,271,760.00 | |
| Nov. 1, 2013 | Director | 37,692 | $23.00 | Sell | $866,916.00 | |
| Nov. 1, 2013 | CEO | 15,000 | $23.24 | Sell | $348,600.00 | |
| Oct. 10, 2013 | Director | 10,000 | $21.63 | Sell | $216,300.00 | |
| Oct. 1, 2013 | CFO | 30,000 | $27.87 | Sell | $836,100.00 | |
| Sept. 20, 2013 | CMO | 35,965 | $25.01 | Sell | $899,484.65 | |
| Sept. 12, 2013 | Director | 66,356 | $22.90 | Sell | $1,519,552.40 | |
| Sept. 10, 2013 | Director | 46,153 | $22.80 | Sell | $1,052,288.40 | |
| Sept. 3, 2013 | Director | 40,000 | $20.28 | Sell | $811,200.00 | |
| Aug. 26, 2013 | Director | 15,000 | $20.68 | Sell | $310,200.00 | |
| Aug. 13, 2013 | CEO | 52,771 | $20.14 | Sell | $1,062,807.94 | |
| Aug. 13, 2013 | CFO | 60,000 | $20.15 | Sell | $1,209,000.00 | |
| June 5, 2013 | Director | 2,340,314 | $14.34 | Buy | $33,560,102.76 | |
| May 15, 2013 | Director | 1,993,000 | $12.50 | Buy | $24,912,500.00 | |
| April 12, 2013 | VP | 60,000 | $12.42 | Sell | $745,200.00 | |
| April 11, 2013 | CFO | 40,000 | $11.06 | Sell | $442,400.00 |
Insiders are both buying and selling ACADIA Pharmaceuticals Inc stock.
The insider traders at ACADIA Pharmaceuticals Inc are: Stephen Davis, Srdjan R Stankovic, James Kihara, Mark C Schneyer, Brendan Teehan, Glenn Baity, Uli Hacksell, Austin D Kim, Bros. Advisors Lp Baker, Laura Brege, Michael J Yang, Elena Ridloff, Torsten Rasmussen, William Mcdowall Wells, Eric Alejandro Miller, Austin D. Kim, Mary Ann Gray, James M Daly, Michael T Borer, Roger Mills, Felix Baker, Thomas Aasen, Thomas H Aasen, Leslie L. Iversen, Edmund Harrigan, Srdjan R. Stankovic, Lester Ph Kaplan, L.P. 14159, Leslie L Iversen, Elizabeth A Garofalo, Terrence O. Moore, Michael J. Yang, and Daniel B Soland
The most active insider trader at ACADIA Pharmaceuticals Inc is Stephen Davis with 26 trades.
Stephen Davis has sold the most ACADIA Pharmaceuticals Inc stock with a total value of $23,353,349.94.
Bros. Advisors Lp Baker has bought the most ACADIA Pharmaceuticals Inc stock with a total value of $449,849,410.39.
The most recent insider trade for ACADIA Pharmaceuticals Inc was on March 26, 2025.
The single biggest insider buy for ACADIA Pharmaceuticals Inc was from Bros. Advisors Lp Baker with a total value of $199,999,985.00 on Nov. 30, 2018.
The single biggest insider sell for ACADIA Pharmaceuticals Inc was from Stephen Davis with a total value of $7,851,000.00 on Dec. 5, 2019.